Evaluating the Utility of Implementing Microfluids for Sperm Preparation Compared to Conventional Method of Density Gradient Centrifugation in a PGT-A Program: a Sibling Oocyte Study

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorART Fertility Clinics LLC

About this trial

In assisted reproductive technology (ART), sperm preparation aims to select the most viable sperm for ICSI. Unlike conventional methods like density gradients or sperm washing, microfluidic techniques mimic natural selection in the female reproductive tract by using laminar flow without centrifugation, reducing the risk of DNA damage. This method isolates highly motile sperm while filtering out debris and immotile cells. Studies show that microfluidics improve embryo quality, increase pregnancy rates, and may lead to higher euploidy rates. Additional benefits include improved safety, scalability, and shorter preparation times.

Eligibility criteria

Qualifiers

Women with at least 8 MII per cycle after denudation (AFC≥8).

Women of all ages.

All embryo qualities ≥BL3CC at the time of biopsy on day 5, 6 and/or 7.

Fresh sperm used from ejaculate with a concentration ≥1 mill/ml and ≥10% motility (A+B).

Disqualifiers

Frozen oocytes samples with severe oligospermia (≤1mill/ml).

PGT-M cases

Sperm with > 1M/ml of round cells

Trial design

Treatments tested in this trial

  • FERTILE Plus

Treatment groups

100 Participants
are divided into 2 treatment groups

Sponsors and collaborators